Menu

Rhythm Pharmaceuticals, Inc. RYTM

Full chart Compare
Set alert

Price alert · RYTM

All alert types
105.02 USD -5.66 (-5.11%)

At closeNov 5, 2026, 6:44 PM EST

105.00 -0.02 -0.02%

After hours · Nov 5, 6:44 PM ET

103.06 Day range 110.66
74.50 52-week range 122.20
YTD
-1.89%
1 year
+5.58%

Revenue & Expenses

Revenue → Gross Profit: $170.26MGross Profit → Expenses: $170.26MRevenue → Cost of Revenue: $19.49MExpenses → Selling, General & Admin: $194.94MExpenses → Research & Development: $167.34MExpenses → Other Expenses: $4.03MExpenses → Income Tax: $497.00KNet Loss → Expenses: $196.54MGross Profit$170.26MNet Loss$196.54MCost of Revenue$19.49MExpenses$366.80MSelling, General & Admin$194.94MResearch & Development$167.34MOther Expenses$4.03MIncome Tax$497.00KRevenue$189.76M

Latest period ending Dec 31, 2025 · select a line to chart its full history

RYTM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
189.76M130.13M77.43M23.64M3.15M
170.26M116.76M68.13M21.50M2.56M
-192.02M-265.50M-184.36M-179.16M-170.06M
-196.54M-260.60M-184.68M-181.12M-69.61M
-3.11-4.34-3.20-3.47-1.40
RYTM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
54.82M89.60M60.41M128.00M59.58M
480.20M392.27M332.75M382.48M329.52M
210.17M227.72M162.99M118.22M45.37M
3.99M3.94M1.26M1.94M2.55M
139.07M21.73M169.76M264.26M284.15M
RYTM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-115.67M-113.88M-136.16M-173.43M-146.00M
-137.15M-48.17M-5.67M28.03M-62.16M
217.96M191.24M74.37M213.83M166.48M
-953.00K0-47.00K-281.00K99.57M
-34.78M29.19M-67.60M68.43M-41.68M